Velnacrine
CAS No. 124027-47-0
Velnacrine( -hydroxytacrine | 1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate | 9-amino-1,2,3,4-tetrahydroacridin-1-ol | 9-ATHCO )
Catalog No. M28020 CAS No. 124027-47-0
Velnacrine is a biochemical.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 52 | In Stock |
|
| 25MG | 85 | In Stock |
|
| 50MG | 125 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVelnacrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionVelnacrine is a biochemical.
-
DescriptionVelnacrine is a biochemical.
-
In Vitro——
-
In Vivo——
-
Synonyms-hydroxytacrine | 1,2,3,4-tetrahydro-9-aminoacridin-1-ol maleate | 9-amino-1,2,3,4-tetrahydroacridin-1-ol | 9-ATHCO
-
PathwayOthers
-
TargetOther Targets
-
RecptorHuman Endogenous Metabolite|Histamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number124027-47-0
-
Formula Weight214.268
-
Molecular FormulaC13H14N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNc1c2C(O)CCCc2nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xu Y, et al. Metabolomics analysis of anaphylactoid reaction reveals its mechanism in a rat model. Asian Pac J Allergy Immunol. 2017 Dec;35(4):224-232.
molnova catalog
related products
-
Lixisenatide acetate
Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
-
Cabazitaxel Impurity...
(4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid a.k.a. polyene-paclitaxel side chain is used as a pharmaceutical intermediate mainly for synthesizing the drug polyene-paclitaxel.
-
2,6-Dimethoxyphenol
2,6-Dimethoxyphenol is a natural product and can be used for the measurement of laccase activity.
Cart
sales@molnova.com